Agios Pharmaceuticals Inc.

09/26/2022 | Press release | Distributed by Public on 09/26/2022 17:22

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Financial Officer